Campus Access Only
All rights reserved. This publication is intended for use solely by faculty, students, and staff of University of the Pacific. No part of this publication may be reproduced, distributed, or transmitted in any form or by any means, now known or later developed, including but not limited to photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the author or the publisher.
Date of Award
2008
Document Type
Thesis - Pacific Access Restricted
Degree Name
Master of Science (M.S.)
Department
Pharmaceutical and Chemical Sciences
First Advisor
William Kehoe
First Committee Member
Allen Shek
Second Committee Member
Patrick Catania
Third Committee Member
Sian Carr-Lopez
Fourth Committee Member
Timothy Smith
Abstract
Heart failure in its simplest terms can be defined as the inability of the heart to pump blood in adequate amounts to maintain circulation. A more descriptive definition of HF is a complex clinical syndrome, where the myocardium is unable to pump sufficient amounts of blood to supply the metabolic needs of the body which may be characterized by dyspnea, fatigue, effort intolerance, and decreased survival. Data from the recent heart disease and stroke statistics update from the American Heart Association has startling implications. The overall prevalence of total cardiovascular disease in the United States is 79.4 million individuals. While the prevalence of heart failure only encompasses 2.5% of the overall total, heart failure affects 57.7 thousand Americans. It is interesting to note that the prevalence of heart failure is equally distributed among men and women. In the past, it was thought of a disease that mostly affected men. The cost of treatment of heart failure is staggering. Since 1979 there has been an overall increase in heart failure hospital discharges of 175 percent. In 2007 it is estimated that the total cost of heart failure is $33.2 billion in the United States. Based on these estimates, the Evaluation of Heart Failure Clinic Alternative - Clinician Effectiveness Study was begun at San Joaquin General Hospital.
Pages
202
ISBN
9780549718697
Recommended Citation
Bandy, Veronica Tovar. (2008). Evaluation of heart failure clinic alternative-clinician effectiveness study. University of the Pacific, Thesis - Pacific Access Restricted. https://scholarlycommons.pacific.edu/uop_etds/2646
To access this thesis/dissertation you must have a valid pacific.edu email address and log-in to Scholarly Commons.
Find in PacificSearch Find in ProQuestIf you are the author and would like to grant permission to make your work openly accessible, please email
Rights Statement
In Copyright. URI: http://rightsstatements.org/vocab/InC/1.0/
This Item is protected by copyright and/or related rights. You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s).
